THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 23 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,089,000 | +5.0% | 35,675,000 | +7.5% | 0.75% | +2.9% |
| Q1 2022 | $31,516,000 | -11.7% | 33,175,000 | -10.2% | 0.73% | -5.9% |
| Q4 2021 | $35,674,000 | -22.5% | 36,925,000 | -25.7% | 0.78% | -35.9% |
| Q3 2021 | $46,013,000 | +60.4% | 49,675,000 | +65.6% | 1.22% | +53.0% |
| Q2 2021 | $28,693,000 | +93.5% | 30,000,000 | +106.9% | 0.80% | +34.5% |
| Q1 2021 | $14,826,000 | -49.8% | 14,500,000 | -37.7% | 0.59% | +37.8% |
| Q1 2017 | $29,550,000 | -18.6% | 23,290,000 | -26.1% | 0.43% | -33.6% |
| Q4 2016 | $36,304,000 | – | 31,500,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 71,957,000 | $88,374,000 | 3.14% |
| Context Capital Management, LLC | 3,500,000 | $4,288,000 | 2.87% |
| Mohican Financial Management, LLC | 1,000,000 | $1,250,000 | 2.40% |
| Verition Fund Management LLC | 8,000,000 | $9,835,000 | 0.79% |
| ZAZOVE ASSOCIATES LLC | 8,170,000 | $10,024,000 | 0.51% |
| Baupost Group | 30,000,000 | $37,125,000 | 0.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,020,000 | $29,431,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 3,007,000 | $3,683,000 | 0.31% |
| CSS LLC/IL | 2,900,000 | $3,556,000 | 0.17% |
| Rock Springs Capital Management LP | 1,500,000 | $1,844,000 | 0.08% |